Ensysce Biosciences, Inc.
ENSC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001716947
In the last 90 days, Ensysce Biosciences, Inc. insiders filed 1 open-market purchase and 0 sales; 18 institutions reported holding it in 13F filings for Q2 2026, worth $261.1K in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Ensysce Biosciences, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 0 | 16 | +16 |
| Shares | 0 | 3.16M | +3.16M |
| Value | $0 | $9.56M | +$9.56M |
New holders (16)
Institutions that held Ensysce Biosciences, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HG Vora Capital Management, LLC | 2,462,500 | $7.46M | 0.28% |
| Stifel Financial Corp | 323,342 | $980.0K | 0.00% |
| Founders Fund Ill Management, LLC | 143,575 | $435.0K | 100.00% |
| Geode Capital Management, LLC | 54,930 | $166.0K | 0.00% |
| Millennium Management LLC | 38,065 | $115.0K | 0.00% |
| FNY Investment Advisers, LLC | 34,113 | $103.0K | 0.05% |
| Virtu Financial LLC | 25,807 | $78.0K | 0.01% |
| Evergreen Capital Management LLC | 14,028 | $43.0K | 0.00% |
| Cresset Asset Management, LLC | 13,717 | $42.0K | 0.00% |
| Jane Street Group, LLC | 12,553 | $38.0K | 0.00% |
| Two Sigma Securities, LLC | 11,228 | $34.0K | 0.01% |
| Tower Research Capital LLC (TRC) | 10,593 | $32.0K | 0.00% |
| Covington Capital Management | 4,800 | $15.0K | 0.00% |
| Morgan Stanley | 3,269 | $10.0K | 0.00% |
| Wolverine Asset Management LLC | 2,791 | $8.00K | 0.00% |
| Wells Fargo & Company | 64 | $0 | 0.00% |
Sold out (0)
Institutions that held Ensysce Biosciences, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
None.